- Trials with a EudraCT protocol (126)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
126 result(s) found for: Current of injury.
Displaying page 1 of 7.
EudraCT Number: 2009-015532-14 | Sponsor Protocol Number: EMR700692-003 | Start Date*: 2010-01-22 | |||||||||||
Sponsor Name:Merck Serono S.A. - Geneva | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II trial to investigate the efficacy and safety of weekly intra-articular (i.a.) injections of 10, 30, and 100 µg o... | |||||||||||||
Medical condition: Knee Cartilage Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) SI (Completed) BG (Prematurely Ended) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001227-31 | Sponsor Protocol Number: NISCI | Start Date*: 2019-06-19 | ||||||||||||||||
Sponsor Name:University Zurich, University Hospital Balgrist, Spinal Cord Injury Center | ||||||||||||||||||
Full Title: Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury | ||||||||||||||||||
Medical condition: spinal cord injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Completed) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-004396-35 | Sponsor Protocol Number: 06078SE-A | Start Date*: 2006-10-25 |
Sponsor Name:Belfast City Hospital Trust | ||
Full Title: Investigation of the anti-inflammatory effects of simvastatin in a model of acute lung injury after inhalation of lipopolysaccharide by healthy volunteers | ||
Medical condition: Acute lung injury (ALI) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-004613-10 | Sponsor Protocol Number: IRIVITC2008 | Start Date*: 2008-09-12 | ||||||||||||||||
Sponsor Name:University College Hospital Galway | ||||||||||||||||||
Full Title: The role of the antioxidants ascorbic acid and n-acetylcysteine in the attenuation of ischaemia reperfusion injury in a human model | ||||||||||||||||||
Medical condition: Ischaemia reperfusion injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005381-35 | Sponsor Protocol Number: EP-DICLO/G-04-2012 | Start Date*: 2013-06-20 | |||||||||||
Sponsor Name:EPIFARMA SRL | |||||||||||||
Full Title: Randomized, double-blind, placebo-controlled, parallel group, multi-centre clinical trial to evaluate safety and efficacy of Diclofenac 1% gel vs. placebo gel in patients with acute traumatic blunt... | |||||||||||||
Medical condition: Patients with acute traumatic blunt soft tissue injury/contusion of the limbs. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001824-23 | Sponsor Protocol Number: CME-LEC1 | Start Date*: 2017-11-29 |
Sponsor Name:Fundación de Investigación Biomédica del Hospital Universitario Puerta de Hierro-Majadahonda (FIBM-HUPHM) | ||
Full Title: Intrathecal administration of autologous adult bone marrow mesenchymal stem cells expanded in the diffuse axonal injury. | ||
Medical condition: Traumatic cerebral injury, chronically established attributed to diffuse axonal injury. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-002083-25 | Sponsor Protocol Number: LIDO2011 | Start Date*: 2011-12-05 | ||||||||||||||||
Sponsor Name:BG University Hospital Bergmannsheil GmbH | ||||||||||||||||||
Full Title: Is there a correlation between the pain relief and the A-delta- and C-fiber function after topical application of lidocaine (5%) in patients with peripheral neuropathic pain? | ||||||||||||||||||
Medical condition: Patients with proven diagnosis of painful peripheral neuropathic pain syndromes as diagnosed as: 1. Peripheral nerve lesion or 2. Postherpetic neuralgia. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001688-66 | Sponsor Protocol Number: SC.14/18-19 | Start Date*: 2019-09-09 | |||||||||||
Sponsor Name:University of Warwick [...] | |||||||||||||
Full Title: Sugar or Salt (SOS) trial: Hyperosmolar therapy in traumatic brain injury | |||||||||||||
Medical condition: Increased intracranial pressure following traumatic brain injury | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000346-18 | Sponsor Protocol Number: BST-SCI-02 | Start Date*: 2021-06-28 | |||||||||||
Sponsor Name:Banc de Sang i Teixits | |||||||||||||
Full Title: A phase I/II, randomized, double-blind, placebo-controlled, parallel, 2-arms clinical trial to assess the safety and efficacy of intrathecal administration of WJ-MSC in chronic traumatic cervical i... | |||||||||||||
Medical condition: Cronic traumatic spinal cord injury | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000140-58 | Sponsor Protocol Number: NL7255100000 | Start Date*: 2020-07-23 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Complement Inhibition: Attacking the Overshooting Inflammation @fter Traumatic Brain Injury - A phase II trial on the safety and efficacy of C1 esterase inhibitor Cinryze for the acute management o... | |||||||||||||
Medical condition: Severe traumatic Brain Injury (TBI) with GCS < 13 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004102-42 | Sponsor Protocol Number: EP-DICLO/2G-01-2015 | Start Date*: 2017-06-06 | |||||||||||
Sponsor Name:Epifarma S.r.l. | |||||||||||||
Full Title: Randomized, multi-center, double-blind, three-armed trial, to evaluate the non-inferiority, efficacy and safety of diclofenac2% gel (Test) versus the originator diclofenac2% gel chosen as Referenc... | |||||||||||||
Medical condition: Acute traumatic events (injury/contusion) classified from mild to moderate pain at rest to the joints, muscles, tendons and ligaments | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) LV (Completed) LT (Completed) HU (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006855-10 | Sponsor Protocol Number: RXQ229 | Start Date*: 2007-02-23 |
Sponsor Name:Buckinghamshire Hospitals NHS Trust | ||
Full Title: A randomised trial of rectal stimulants for neurogenic bowel management after spinal cord injury | ||
Medical condition: Response of the neurogenic bowel after spinal cord injury to pharmacological rectal stimulants | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002991-28 | Sponsor Protocol Number: N/A | Start Date*: 2016-10-24 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: GRASP: Getting it Right: Addressing Shoulder Pain. Clinical and cost effectiveness of progressive exercise compared to best practice advice, with or without corticosteroid injection, for the treat... | |||||||||||||
Medical condition: Rotator Cuff Partial Tear (not full tear) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-005375-16 | Sponsor Protocol Number: A-99-52120-162 | Start Date*: 2012-02-20 | |||||||||||
Sponsor Name:Institut Produits Synthèse (IPSEN) AB | |||||||||||||
Full Title: A PHASE III PROSPECTIVE, MULTI-CENTER, RANDOMISED, EVALUATOR-BLINDED STUDY TO COMPARE NEUROMUSCULAR JUNCTION (NMJ) TARGETED TECHNIQUE FOR DYSPORT INJECTIONS IN UPPER LIMB SPASTICITY POST STROKE OR ... | |||||||||||||
Medical condition: Upper limb spasticity post stroke or traumatic brain injury. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) FI (Completed) DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004994-30 | Sponsor Protocol Number: NL68837.091.21 | Start Date*: 2022-02-08 |
Sponsor Name:Roessingh | ||
Full Title: Pulmonary function and sleep related disorders during cervical admission of intrathecal baclofen in spinal cord injury; a safety study | ||
Medical condition: Spasticity in patients with spinal cord injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003771-18 | Sponsor Protocol Number: GWSP08258 | Start Date*: 2013-08-06 | |||||||||||
Sponsor Name:GW Pharma Ltd. | |||||||||||||
Full Title: The efficacy, safety and tolerability of Sativex as an adjunctive treatment to existing anti-spasticity medications in children aged 8 to 18 years with spasticity due to cerebral palsy or traumatic... | |||||||||||||
Medical condition: Spasticity due to cerebral palsy (CP) or traumatic central nervous system injury. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003073-15 | Sponsor Protocol Number: 0504 | Start Date*: 2016-02-12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Research Governance, University of Leicester | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: HYDration and bicarbonate to prevent acute Renal injury after endovascular Aneurysm repair: pilot-feasibility randomized controlled study (HYDRA pilot trial) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Acute kidney injury post endovascular repair of the abdominal aortic aneurysm. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-006034-18 | Sponsor Protocol Number: 06004 | Start Date*: 2007-05-21 | |||||||||||
Sponsor Name:Medicure International Inc. | |||||||||||||
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO EVALUATE THE CARDIOPROTECTIVE EFFECTS OF MC-1 IN PATIENTS UNDERGOING HIGH-RISK CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY | |||||||||||||
Medical condition: For treatment to reduce cardiovascular events associated with ischemic damage and/or ischemia-reperfusion injury in patients undergoing CABG surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003088-87 | Sponsor Protocol Number: WWU20_0016 | Start Date*: 2021-11-22 | |||||||||||||||||||||||||||||||
Sponsor Name:Westfälische Wilhelms-Universität Münster | |||||||||||||||||||||||||||||||||
Full Title: Biomarker-guided implementation of angiotensin-II (AT-II) to reduce the occurrence of kidney damage after cardiac surgery | |||||||||||||||||||||||||||||||||
Medical condition: Cardiac surgical patients at high risk for AKI | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020452-64 | Sponsor Protocol Number: version2.0 | Start Date*: 2010-10-05 | |||||||||||
Sponsor Name:Hull and East Yorkshire Hospitals NHS Trust | |||||||||||||
Full Title: A prospective randomisd open label study to determine the effects of intravenous iron administration on markers of acute kidney injury in chronic kidney disease (CKD) | |||||||||||||
Medical condition: patients with known chonic kidney disease with functional or absolute Iron deficiency Anaemia, and are greater than 18 years will be given repleacement iron therapy accoring to current local protoc... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
